AGL vs. AORT
AGL (agilon health, inc.) and AORT (Artivion, Inc.) are both stocks. Both are in the Healthcare sector — AGL in Medical Care Facilities, AORT in Medical Devices. Over the past 5 years, AGL returned -37.59%/yr vs -6.59%/yr for AORT. At a 0.21 correlation, their price movements are largely independent.
Performance
AGL vs. AORT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AGL achieves a 403.85% return, which is significantly higher than AORT's -55.23% return.
AGL
- 1D
- -6.26%
- 1M
- 193.27%
- YTD
- 403.85%
- 6M
- 425.68%
- 1Y
- 54.22%
- 3Y*
- -44.43%
- 5Y*
- -37.59%
- 10Y*
- —
AORT
- 1D
- -2.99%
- 1M
- -43.61%
- YTD
- -55.23%
- 6M
- -54.99%
- 1Y
- -28.87%
- 3Y*
- 10.12%
- 5Y*
- -6.59%
- 10Y*
- 5.65%
AGL vs. AORT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
AGL agilon health, inc. | 403.85% | -63.75% | -84.86% | -22.24% | -40.22% | -12.90% |
AORT Artivion, Inc. | -55.23% | 59.53% | 59.90% | 47.52% | -40.44% | -10.15% |
Correlation
The correlation between AGL and AORT is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Apr 16, 2021 | 0.21 |
Fundamentals
AGL:
$1.45B
AORT:
$1.02B
AGL:
-$22.51
AORT:
$0.24
AGL:
0.25
AORT:
2.15
AGL:
7.97
AORT:
2.25
AGL:
$5.82B
AORT:
$458.69M
AGL:
-$225.14M
AORT:
$292.61M
AGL:
-$340.64M
AORT:
$53.91M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AGL vs. AORT — Risk / Return Rank
AGL
AORT
AGL vs. AORT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for agilon health, inc. (AGL) and Artivion, Inc. (AORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AGL | AORT | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.32 | -0.57 | +0.88 |
Sortino ratioReturn per unit of downside risk | 1.94 | -0.53 | +2.48 |
Omega ratioGain probability vs. loss probability | 1.26 | 0.91 | +0.35 |
Calmar ratioReturn relative to maximum drawdown | 0.65 | -0.54 | +1.19 |
Martin ratioReturn relative to average drawdown | 0.97 | -1.68 | +2.65 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| AGL | AORT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.32 | -0.57 | +0.88 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.37 | -0.15 | -0.22 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.13 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.34 | 0.08 | -0.42 |
Drawdowns
AGL vs. AORT - Drawdown Comparison
The maximum AGL drawdown since its inception was -99.27%, roughly equal to the maximum AORT drawdown of -95.72%. Use the drawdown chart below to compare losses from any high point for AGL and AORT.
Loading charts...
Drawdown Indicators
| AGL | AORT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.27% | -95.72% | -3.55% |
Max Drawdown (1Y)Largest decline over 1 year | -86.98% | -57.13% | -29.85% |
Max Drawdown (3Y)Largest decline over 3 years | -98.50% | -57.13% | -41.37% |
Max Drawdown (5Y)Largest decline over 5 years | -99.27% | -66.35% | -32.92% |
Max Drawdown (10Y)Largest decline over 10 years | — | -72.00% | — |
Current DrawdownCurrent decline from peak | -91.98% | -57.13% | -34.85% |
Average DrawdownAverage peak-to-trough decline | -67.76% | -56.64% | -11.12% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 58.05% | 18.42% | +39.63% |
Volatility
AGL vs. AORT - Volatility Comparison
agilon health, inc. (AGL) has a higher volatility of 82.04% compared to Artivion, Inc. (AORT) at 34.56%. This indicates that AGL's price experiences larger fluctuations and is considered to be riskier than AORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AGL | AORT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 82.04% | 34.56% | +47.48% |
Volatility (6M)Calculated over the trailing 6-month period | 126.50% | 42.95% | +83.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 172.82% | 51.21% | +121.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 102.55% | 44.88% | +57.67% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 101.67% | 44.74% | +56.93% |
Dividends
AGL vs. AORT - Dividend Comparison
Neither AGL nor AORT has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AGL agilon health, inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AORT Artivion, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.11% |
Financials
AGL vs. AORT - Financials Comparison
This section allows you to compare key financial metrics between agilon health, inc. and Artivion, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AGL vs. AORT - Profitability Comparison
AGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, agilon health, inc. reported a gross profit of 0.00 and revenue of 1.42B. Therefore, the gross margin over that period was 0.0%.
AORT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Artivion, Inc. reported a gross profit of 75.45M and revenue of 116.34M. Therefore, the gross margin over that period was 64.9%.
AGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, agilon health, inc. reported an operating income of 4.00M and revenue of 1.42B, resulting in an operating margin of 0.3%.
AORT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Artivion, Inc. reported an operating income of 5.79M and revenue of 116.34M, resulting in an operating margin of 5.0%.
AGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, agilon health, inc. reported a net income of 29.97M and revenue of 1.42B, resulting in a net margin of 2.1%.
AORT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Artivion, Inc. reported a net income of 1.42M and revenue of 116.34M, resulting in a net margin of 1.2%.
Frequently Asked Questions
AGL and AORT have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AGL has higher volatility (82.04%) compared to AORT (34.56%). In terms of maximum drawdown, AGL dropped -99.27% vs AORT's -95.72%.
AGL currently has the higher Sharpe Ratio (0.32 vs -0.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AGL and AORT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer